Meeting Demand For Enhanced Cleaning Protocols While Reducing Bioburden

With the pharmaceutical industry shifting towards more stringent cleaning regimes to reduce bioburden, traditional protein A resins are facing unprecedented challenges. Renato Azevedo, our Senior Director, highlights how Purolite's DurA Cycle A50 is engineered to overcome these hurdles. This advanced resin’s caustic resistance allows for half-molar CIP protocols, ensuring minimal microbial contamination and a significantly extended resin lifespan. This innovation not only cuts operating costs but also boosts target molecule output, simplifying downstream purification.

Ecolab's commitment to innovation, showcased through DurA Cycle A50, is setting new standards in the industry. Discover how DurA Cycle A50 can redefine your bioprocessing. Watch the video now to learn more.